MétaCan
Menu
Back to cohort
Record W2193183011 · doi:10.1093/jnci/djv315

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

2015· article· en· W2193183011 on OpenAlexfundno aff
Huong Meeks, Honglin Song, Kyriaki Michailidou, Manjeet K. Bolla, Joe Dennis, Qin Wang, Daniel Barrowdale, Debra Frost, Lesley McGuffog, Bing Feng, Saundra S. Buys, John L. Hopper, Melissa C. Southey, Andrea Tesoriero, Paul A. James, Fiona Bruinsma, Ian Campbell, Annegien Broeks, Marjanka K. Schmidt, Frans B.L. Hogervorst, Matthias W. Beckman, Peter A. Fasching, Olivia Fletcher, Nichola Johnson, Elinor J. Sawyer, Elio Ríboli, Susana Banerjee, Usha Menon, Ian Tomlinson, Barbara Burwinkel, Ute Hamann, Frederik Marmé, Anja Rudolph, Ramūnas Janavičius, Laima Tihomirova, Nadine Tung, Judy E. Garber, Daniel W. Cramer, Kathryn L. Terry, Elizabeth M. Poole, Shelley S. Tworoger, Cecilia M. Dorfling, Elizabeth J. van Rensburg, Andrew K. Godwin, Pascal Guénel, Thérèse Truong, Dominique Stoppa‐Lyonnet, Francesca Damiola, Sylvie Mazoyer, Olga M. Sinilnikova, Claudine Isaacs, Christine Maugard, Stig E. Bojesen, Henrik Flyger, Anne‐Marie Gerdes, Thomas van Overeem Hansen, Susanne K. Kjær, Claus Høgdall, Estrid Høgdall, Inge Søkilde Pedersen, Mads Thomassen, Javier Benı́tez, Anna González‐Neira, Ana Osório, Miguel de la Hoya, Pedro Pérez Segura, Orland Dı́ez, Conxi Lázaro, Joan Brunet, Hoda Anton‐Culver, Eunjung Lee, Esther M. John, Susan L. Neuhausen, Yuan Chun Ding, Danielle Castillo, Jeffrey N. Weitzel, Patricia A. Ganz, Robert L. Nussbaum, Salina Chan, Beth Y. Karlan, Jenny Lester, Anna H. Wu, Simon A. Gayther, Susan J. Ramus, Weiva Sieh, Alice S. Whittermore, Álvaro N.A. Monteiro, Catherine M. Phelan, Mary Beth Terry, Marion Piedmonte, Kenneth Offit, Mark E. Robson, Douglas A. Levine, Kirsten B. Moysich, Rikki Cannioto, Sara H. Olson, Mary B. Daly, Katherine L. Nathanson, Susan M. Domchek, Karen H. Lu, Dong Liang, Michelle A. T. Hildebrant, Roberta B. Ness, Francesmary Modugno, Leigh Pearce, Marc T. Goodman, Pamela J. Thompson, Hermann Brenner, Katja Butterbach, Alfons Meindl, Barbara Wappenschmidt, Hiltrud Brauch, Thomas Brüning, Carl Blomqvist, Sofia Khan, Heli Nevanlinna, Liisa M. Pelttari, Kristiina Aittomäki, Ralf Bützow, Natalia Bogdanova, Thilo Dörk, Annika Lindblom, Sara Margolin, Johanna Rantala, Veli-Matti Kosma, Diether Lambrechts, Patrick Neven, Kathleen Claes, Tom Van Maerken, Jenny Chang-Claude, Dieter Flesch‐Janys, Florian Heitz, Raymonda Varon-Mateeva, Paolo Peterlongo, Paolo Radice, Alessandra Viel, Monica Barile, Bernard Peissel, Siranoush Manoukian, Marco Montagna, Cristina Oliani, Ana Peixoto, Manuel R. Teixeira, Anita Collavoli, Emily Hallberg, Janet E. Olson, Ellen L. Goode, Steven N. Hart, Hermela Shimelis, Julie M. Cunningham, Graham G. Giles, Roger L. Milne, Sue Healey, Kathy Tucker, Christopher A. Haiman, Brian E. Henderson, Mark S. Goldberg, Marc Tischkowitz, Jacques Simard, Penny Soucy, Nhu D. Le, Anne‐Lise Børresen‐Dale, Vessela N. Kristensen, Helga B. Salvesen, Line Bjørge, Elisa V. Bandera, Harvey A. Risch, Wei Zheng, Alicia Beeghly‐Fadiel, Hui Cai, Katri Pylkäs, Robert A.E.M. Tollenaar, Ans M. W. van der Ouweland, Irene L. Andrulis, Julia A. Knight, Steven A. Narod, Peter Devilee, Robert Winqvist, Jonine D. Figueroa, Mark H. Greene, Jennifer T. Loud, Montserrat García‐Closas, Minouk J. Schoemaker, Kamila Czene, Hatef Darabi, Iain A. McNeish, Nadeem Siddiquil, Rosalind Glasspool, Ava Kwong, Sue K. Park, Soo‐Hwang Teo, Sook-Yee Yoon, Keitaro Matsuo, Satoyo Hosono, Yin Ling Woo, Yu-Tang Gao, Lenka Foretová, Christian F. Singer, Christine Rappaport-Feurhauser, Eitan Friedman, Yael Laitman, Gad Rennert, Evgeny N. Imyanitov, Peter J. Hulick, Olufunmilayo I. Olopade, Leigha Senter, Edith Oláh, Jennifer A. Doherty, Joellen M. Schildkraut, Linetta B. Koppert, Lambertus A. Kiemeney, Leon F.A.G. Massuger, Linda S. Cook, Tanja Pejović, Jingmei Li, Åke Borg, Anna Öfverholm, Mary Anne Rossing, Nicolas Wentzensen, Karin Henriksson, Angela Cox, Simon S. Cross, Barbara Pasini, Mitul Shah, Maria Kabisch, Diana Torres, Anna Jakubowska, Jan Lubiński, Jacek Gronwald, Bjarni A. Agnarsson, Jolanta Kupryjańczyk, Joanna Moes-Sosnowska, Florentia Fostira, Irene Konstantopoulou, Susan Slager, Michael E. Jones, Antonis C. Antoniou, Andrew Berchuck, Anthony J. Swerdlow, Georgia Chenevix‐Trench, Alison M. Dunning, Paul D.P. Pharoah, Per Hall, Douglas F. Easton, Fergus J. Couch, Amanda B. Spurdle, David E. Goldgar

Bibliographic record

VenueJNCI Journal of the National Cancer Institute · 2015
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicBRCA gene mutations in cancer
Canadian institutionsnot available
FundersNational Cancer InstituteCanadian Institutes of Health ResearchFox Chase Cancer CenterNational Institute for Health and Care ResearchNational Health and Medical Research CouncilCancer Research UKGovernment of CanadaGenome CanadaFrancis Crick InstituteWellcome TrustRoswell Park Cancer InstituteAmerican Breast Cancer FoundationGénome QuébecMcGill UniversityNational Institutes of HealthOvarian Cancer Research FundEuropean CommissionBreast Cancer Research FoundationMedical Research CouncilMayo Clinic
KeywordsOncologyProstateMedicineProstate cancerInternal medicineGynecologyCancer

Abstract

fetched live from OpenAlex

BACKGROUND: The K3326X variant in BRCA2 (BRCA2*c.9976A>T; p.Lys3326*; rs11571833) has been found to be associated with small increased risks of breast cancer. However, it is not clear to what extent linkage disequilibrium with fully pathogenic mutations might account for this association. There is scant information about the effect of K3326X in other hormone-related cancers. METHODS: Using weighted logistic regression, we analyzed data from the large iCOGS study including 76 637 cancer case patients and 83 796 control patients to estimate odds ratios (ORw) and 95% confidence intervals (CIs) for K3326X variant carriers in relation to breast, ovarian, and prostate cancer risks, with weights defined as probability of not having a pathogenic BRCA2 variant. Using Cox proportional hazards modeling, we also examined the associations of K3326X with breast and ovarian cancer risks among 7183 BRCA1 variant carriers. All statistical tests were two-sided. RESULTS: The K3326X variant was associated with breast (ORw = 1.28, 95% CI = 1.17 to 1.40, P = 5.9x10(-) (6)) and invasive ovarian cancer (ORw = 1.26, 95% CI = 1.10 to 1.43, P = 3.8x10(-3)). These associations were stronger for serous ovarian cancer and for estrogen receptor-negative breast cancer (ORw = 1.46, 95% CI = 1.2 to 1.70, P = 3.4x10(-5) and ORw = 1.50, 95% CI = 1.28 to 1.76, P = 4.1x10(-5), respectively). For BRCA1 mutation carriers, there was a statistically significant inverse association of the K3326X variant with risk of ovarian cancer (HR = 0.43, 95% CI = 0.22 to 0.84, P = .013) but no association with breast cancer. No association with prostate cancer was observed. CONCLUSIONS: Our study provides evidence that the K3326X variant is associated with risk of developing breast and ovarian cancers independent of other pathogenic variants in BRCA2. Further studies are needed to determine the biological mechanism of action responsible for these associations.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.008

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.023
GPT teacher head0.288
Teacher spread0.265 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations92
Published2015
Admission routes1
Has abstractyes

Explore more

Same venueJNCI Journal of the National Cancer InstituteSame topicBRCA gene mutations in cancerFrench-language works237,207